Response of pemphigus vulgaris to anti‐CD20 antibody therapy (rituximab) may be delayed
Response of pemphigus vulgaris to anti‐CD20 antibody therapy (rituximab) may be delayed
复制标题
寻常型天疱疮对抗 CD20 抗体治疗(利妥昔单抗)的反应可能会延迟
DOI:
10.1111/j.1365-2230.2005.01941.x
复制
发表时间:
2006
期刊:
影响因子:
--
通讯作者:
R. Williams
中科院分区:
文献类型:
--
作者:
A. Belgi;M. Azeez;C. Hoyle;R. Williams
host-disease-like dermopathy in a child with CD4+ cell microchimerism. Dermatology 2005; 210: 68–71. 3 Leber B, Walker IR, Rodriguez A et al. Reinduction of remission of chronic myeloid leukemia by donor leukocyte transfusion following relapse after bone marrow transplantation: recovery complicated by initial pancytopenia and late dermatomyositis. Bone Marrow Transplant 1993; 12: 405–7. 4 Ollivier I, Wolkenstein P, Gherardi R et al. Dermatomyositislike graft-versus-host disease. Br J Dermatol 1998; 138: 558–9. 5 Tsunemi Y, Ihn H, Nakamura K et al. Post-transplantation chronic graft-versus-host disease with overlapping features similar to those of various collagen diseases. Int J Dermatol 2003; 42: 292–4.